Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial.
about
Emerging treatment options for nasopharyngeal carcinomaUniversity Cooperation Platform (UCP) between Christian-Albrechts-University Kiel (Germany) and Chiang Mai University (Thailand): implementation of image-guided gynecological brachytherapyDefinitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.Concurrent chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma.Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.A meta-analysis comparing cisplatin-based to carboplatin-based chemotherapy in moderate to advanced squamous cell carcinoma of head and neck (SCCHN).Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.Concurrent hyperfractionated chemoradiotherapy for head and neck squamous cell carcinoma: the prognostic impact of the overall treatment time and completion rates of chemotherapySystemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinoma.Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.Treatment of head and neck cancers: issues for clinical pharmacists.Unknown primary cancer of the head and neck: a multidisciplinary approach.In squamous cell head and neck cancer: which platinum, how much and how often?Nutlin-3, A P53-Mdm2 Antagonist For Nasopharyngeal Carcinoma Treatment.ACR Appropriateness criteria® for nasopharyngeal carcinoma.Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma.Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India.Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.The incidence and predictors of symptomatic venous thromboembolism associated with peripherally inserted central catheters in patients with nasopharyngeal carcinoma.
P2860
Q26995560-B40DCD42-B957-4E19-A002-3CC836FC6ACEQ28083557-972E2393-DBB5-4EEC-A5AA-A5AC0EBF6F4AQ30248350-320DDB86-C529-4713-981E-0F2299772FE9Q33395652-ECE6BC51-29D1-4A64-8435-69425C4AADA6Q33426350-54C6D775-41F0-4E08-8ACB-50EDE01450D0Q33429085-17076578-7032-4C74-B745-AA1CA879DA48Q33907143-83EB6B11-77A4-41C5-B706-6315BF8D4F1FQ35991873-25AC105F-239A-4122-A9B0-5497EE0DB2ABQ37171008-E86F3B4A-6AAA-4944-B029-C91C7A7A3D40Q37197508-BAB8379E-7DF1-4351-AC6A-8619B04872FBQ37230165-86310106-B6B6-41A6-A25A-D1E2D94965C0Q37461437-DDCC81CD-C554-47B9-9DAB-544257AC9C61Q37842965-CB877773-43DC-4127-BA1B-24AF43253571Q38226689-5C0788E9-AB4A-4C43-9A84-E4C636E9DDD4Q38656647-BBBA7120-CDF1-4B7F-8D0B-3E16B662CF2AQ38821590-C878AB1D-3DDC-4ADB-BBE9-57317D850F0DQ38921784-5D0B7EE2-A992-4C04-868D-24F74A642238Q39328868-53781689-0B8F-4300-BDA1-4DF8A8A490B6Q42114736-03E18096-79CA-4766-AAF0-844260CDB776Q48687384-0803138F-9872-45B9-BD84-010F4407E88FQ50434295-AAC2A041-5201-4491-AB60-7592681064B8Q55411209-521FD9CF-F586-4346-B0F5-A636E8464DCE
P2860
Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non-inferiority, open trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@ast
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@en
type
label
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@ast
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@en
prefLabel
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@ast
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@en
P2093
P1476
Chemoradiation comparing cispl ...... , non-inferiority, open trial.
@en
P2093
Ekkasit Tharavichitkul
Judith Ford
Pimkhuan Kamnerdsupaphon
Vicharn Lorvidhaya
Vimol Sukthomya
Yupa Sumitsawan
P304
P356
10.1016/J.EJCA.2007.03.022
P577
2007-04-27T00:00:00Z